Case Studies

U.S. Pharma Consulting (USPC) provides full regulatory and commercialization strategy, product launch excellence, and manufacturing optimization to help clients transform promising molecules into commercial success. We align regulatory, market access, commercialization, and launch execution with your business objectives to accelerate readiness, strengthen market position, and maximize long-term value. Please explore our Industry Insights and Case Studies.

Where AI-enabled biopharma workflows are gaining traction

Slide Deck

May 2026

Medical Device Quality System Alignment and Regulatory Readiness

Case Study

May 2026

JPM 2026 Signal: AI Is Moving from Talk to Transactions & CMS priorities around Drug-to-Drug interaction and patient safety

Case Study

April 2026

2026 Segment-Specific Industry Update Brand/Innovator Drugs, Generics, Biotech, Cell & Gene Therapy and PBM’s

Case Study

April 2026

AMR at the Crossroads: AI-Enabled Strategy for Antimicrobial Innovation, Access, and Commercial Sustainability

Case Study

March 2026

US Antibiotics: A U.S. Led Strategic Focus with Global Market Influence Repositioning a Core U.S.Asset as a Strategic Opportunity

Case Study

March 2026

How AI Aligns with Existing EHR Clinical Decision Support Rule Workflows - Part 1

Case Study

February 2026

AI Translating the Clinical and Economic Framework into a Realistic, Governance-Aligned Monetization Pathway - Part 2

Case Study

February 2026

AI will Functions not as a Diagnostic System or Alerting Overlay, but as a Utilization Management Enabler that Strengthens Existing Clinical and Regulatory Workflows - Part 3

Case Study

February 2026

AI is the Prescription Safety AI Connector Solution – Connecting all the Dots

Case Study

December 2025

Mission Critical 505 (b)(1) or (2) Product Launch Excellence & Value Proposition Workflow

Workflow Chart

November 2024

FDA Discovery, Development, Approval, Lifecycle Circle of Life

Workflow Chart

October 2024

Rapid Development, Implementation and U.S. Market Entry of a Telehealth, and Direct-to-Patient Business:

Case Study

May 2023

Antibiotic Manufacturer's Rapid U.S. Market Entry and Commercialization Expansion:

Case Study

May 2023

Hear what our clients have to say.

U.S. Pharma Consulting (USPC) has been an innovative partner in the development of our generic pharmaceutical manufacturing business in the USA. Their depth of knowledge of the trade and extensive contacts has allowed us to establish a foothold in the very complex marketplace. USPC provided timely guidance in the launch of our strong distribution platform that will pay dividends in years to come. Working together with USPC, we expect to become a thriving business in the USA and numerous Global Markets.
Generic Manufacturer President
I would like to express appreciation for USPC’s outstanding contributions made to our drug and medtech development company. USPC’s passion and comprehensive commercial understanding for every single business aspect was remarkable. USPC AI business guidance and contributions were extremely helpful; but, most significantly, USPC has instilled a real-world and AI business approach by providing a value proposition understanding. This commitment created a “Best-in-Class” consulting experience.
Drug & Med Tech Development Company
Connect with USPC today for your free consultation.
Let’s start a conversation.
Get Started